Gene · 2817
Papers2,608
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,608
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unraveling the Mechanism of Immunity and Inflammation Related to Molecular Signatures Crosstalk Among Obesity, T2D, and AD: Insights From Bioinformatics Approaches. | Bioinform Biol Insights | 2023 | 37124128 | PubTator, text mining | PubMed |
| An Unusual Case of Hepatocellular Carcinoma in a Healthy Teenager. | J Investig Med High Impact Case Rep | 2023 | 37119001 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Breast Cancer: From Biology and Function to Clinical Diagnosis and Therapeutic Management. | Int J Mol Sci | 2023 | 37108371 | PubTator, text mining | PubMed |
| Integrated analysis of circulating cell free nucleic acids for cancer genotyping and immune phenotyping of tumor microenvironment. | Front Genet | 2023 | 37091783 | PubTator, text mining | PubMed |
| Mechanotransduction and the endothelial glycocalyx: Interactions with membrane and cytoskeletal proteins to transduce force. | Curr Top Membr | 2023 | 37080680 | PubTator, text mining | PubMed |
| Enhancing clinical potential of liquid biopsy through a multi-omic approach: A systematic review. | Front Genet | 2023 | 37077538 | PubTator, text mining | PubMed |
| Wnt3a-Loaded Extracellular Vesicles Promote Alveolar Epithelial Regeneration after Lung Injury. | Adv Sci (Weinh) | 2023 | 37072558 | PubTator, text mining | PubMed |
| A Scalable High-Throughput Isoelectric Fractionation Platform for Extracellular Nanocarriers: Comprehensive and Bias-Free Isolation of Ribonucleoproteins from Plasma, Urine, and Saliva. | ACS Nano | 2023 | 37071723 | PubTator, text mining | PubMed |
| Pathological angiogenesis: mechanisms and therapeutic strategies. | Angiogenesis | 2023 | 37060495 | PubTator, text mining | PubMed |
| Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis. | Cell Death Discov | 2023 | 37059713 | PubTator, text mining | PubMed |
| Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 37059586 | PubTator, text mining | PubMed |
| The role of extracellular vesicles in cancer. | Cell | 2023 | 37059067 | PubTator, text mining | PubMed |
| Insights on the Biomarker Potential of Exosomal Non-Coding RNAs in Colorectal Cancer: An In Silico Characterization of Related Exosomal lncRNA/circRNA-miRNA-Target Axis. | Cells | 2023 | 37048155 | PubTator, text mining | PubMed |
| MALDI Imaging, a Powerful Multiplex Approach to Decipher Intratumoral Heterogeneity: Combined Hepato-Cholangiocarcinomas as Proof of Concept. | Cancers (Basel) | 2023 | 37046807 | PubTator, text mining | PubMed |
| Current Applications of Liquid Biopsy in Gastrointestinal Cancer Disease-From Early Cancer Detection to Individualized Cancer Treatment. | Cancers (Basel) | 2023 | 37046585 | PubTator, text mining | PubMed |
| A Statistical Approach to the Diagnosis and Prediction of HCC Using CK19 and Glypican 3 Biomarkers. | Diagnostics (Basel) | 2023 | 37046471 | PubTator, text mining | PubMed |
| Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer. | Cell Oncol (Dordr) | 2023 | 37040056 | PubTator, text mining | PubMed |
| The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancer. | Nat Commun | 2023 | 37031249 | PubTator, text mining | PubMed |
| The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies. | Front Immunol | 2023 | 37020537 | PubTator, text mining | PubMed |
| Analyzing and Comparing Omicron Lineage Variants Protein-Protein Interaction Network Using Centrality Measure. | SN Comput Sci | 2023 | 37016628 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2817/papers?page=17